Efficacy and Safety of Direct Oral Anticoagulants for Risk of Cancer-Associated Venous Thromboembolism

Efficacy and safety of direct oral anticoagulants (DOACs) for preventing primary and recurrent venous thromboembolism (VTE) in patients with cancer remain unclear. In this study, we conducted a systematic review to summarize the most up-to-date evidence from randomized controlled trials (RCTs). Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Jie, Zhang, Xuhui, Lip, Gregory Y. H., Shu, Xiaochen, Thabane, Lehana, Tian, Junzhang, Li, Guowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714916/
https://www.ncbi.nlm.nih.gov/pubmed/31132874
http://dx.doi.org/10.1177/1076029619853629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714916/
https://www.ncbi.nlm.nih.gov/pubmed/31132874
http://dx.doi.org/10.1177/1076029619853629

Ejemplares similares